Physician

Ali Abbas Bukhari, M.D.

According to 2025 Medicare claims, Ali Bukhari, M.D. (NPI: 1760724017) practices hematology/oncology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Anne Arundel, MD. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY P.A. (NPI: 1396710703; TIN: 113652573) and primary practice location at 21401-9998.

Bukhari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 549 traditional Medicare patients, billed 116,801 HCPCS/CPT codes, and received $1,950,550 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 781 prescription claims across 128 beneficiaries totaling $1,723,137 in drug costs, led by Ojjaara (Momelotinib Dihydrochloride). 2017 DME data shows 47 claims. Open Payments data shows 61 records totaling $1,468. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,075 to $1,723,137. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.